Author:
Marsé Hilde,Van Cutsem Eric,Grothey Axel,Valverde Sonia
Subject
Oncology (nursing),General Medicine
Reference28 articles.
1. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer;Blum;Journal of Clinical Oncology,1999
2. Multicenter, phase II study of oral capecitabine in taxane-pretreated metastatic breast carcinoma patients;Blum;Cancer,2001
3. A phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors;Cassidy;Clinical Cancer Research,1998
4. First-line oral capecitabine therapy in metastatic colorectal cancer;Cassidy;Annals of Oncology,2002
5. Cassidy, J., Scheithauer, W., McKendrick, J., Kröning, H., Nowacki, M.P., Seitz, J.F., Twelves, C., Van Hazel, G., Wong, A., Díaz-Rubio, E., On Behalf Of X-act Study Investigators, 2004. Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): efficacy results of a phase III trial. Proceedings of the American Society of Clinical Oncology (abstract 3509).
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献